Loss of GM-CSF signalling in non-haematopoietic cells increases NSAID ileal injury
about
Loss of guanylyl cyclase C (GCC) signaling leads to dysfunctional intestinal barrierNatural compound methyl protodioscin protects against intestinal inflammation through modulation of intestinal immune responses.Enterocyte STAT5 promotes mucosal wound healing via suppression of myosin light chain kinase-mediated loss of barrier function and inflammation.GM-CSF and the role of myeloid regulatory cells in the pathogenesis and treatment of Crohn's disease.Barrier protection via Toll-like receptor 2 signaling in porcine intestinal epithelial cells damaged by deoxynivalnol.GM-CSF produced by nonhematopoietic cells is required for early epithelial cell proliferation and repair of injured colonic mucosaGranulocyte macrophage colony-stimulating factor and the intestinal innate immune cell homeostasis in Crohn's disease.Granulocyte-macrophage colony-stimulating factor (GM-CSF) is released by female mouse bladder urothelial cells and expressed by the urothelium as an early response to lipopolysaccharides (LPS).Activated STAT5 confers resistance to intestinal injury by increasing intestinal stem cell proliferation and regeneration.Paediatric Crohn disease patients with stricturing behaviour exhibit ileal granulocyte-macrophage colony-stimulating factor (GM-CSF) autoantibody production and reduced neutrophil bacterial killing and GM-CSF bioactivity.GM-CSF: a role in immune and inflammatory reactions in the intestine.
P2860
Q33816018-A597DD59-1DF3-46BA-88BC-E96B1180E6B6Q35664929-3A31F376-2B88-4671-AF32-0792621785F1Q35836695-B634723F-8855-41A8-97E7-821B01E8D8A8Q36339061-7751315D-0193-48D7-895E-994753D86DE1Q36560606-1D68EFF2-3375-43F6-9417-8EDADEECCDCDQ36586289-F3A1DF12-B044-44D6-B2B4-572FE4723991Q38185880-F60E940F-B99C-403D-A4E8-01785CAB0388Q40639060-FE3CDCAE-B80F-4C1B-B607-98C15FFB755CQ42206679-2E36936E-51AB-4803-A4DB-0F39261D67F2Q42437439-86075729-8123-44F5-8A4E-B4222FF37DE2Q42616336-4D30DC49-F289-4260-BC18-ED314E953FF8
P2860
Loss of GM-CSF signalling in non-haematopoietic cells increases NSAID ileal injury
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Loss of GM-CSF signalling in non-haematopoietic cells increases NSAID ileal injury
@ast
Loss of GM-CSF signalling in non-haematopoietic cells increases NSAID ileal injury
@en
Loss of GM-CSF signalling in non-haematopoietic cells increases NSAID ileal injury
@nl
type
label
Loss of GM-CSF signalling in non-haematopoietic cells increases NSAID ileal injury
@ast
Loss of GM-CSF signalling in non-haematopoietic cells increases NSAID ileal injury
@en
Loss of GM-CSF signalling in non-haematopoietic cells increases NSAID ileal injury
@nl
prefLabel
Loss of GM-CSF signalling in non-haematopoietic cells increases NSAID ileal injury
@ast
Loss of GM-CSF signalling in non-haematopoietic cells increases NSAID ileal injury
@en
Loss of GM-CSF signalling in non-haematopoietic cells increases NSAID ileal injury
@nl
P2093
P2860
P356
P1433
P1476
Loss of GM-CSF signalling in non-haematopoietic cells increases NSAID ileal injury
@en
P2093
Bruce Trapnell
Charles Samson
Ingrid Jurickova
Jonathan Gully
Katherine Groschwitz
Shila Gilbert
Simon Hogan
P2860
P304
P356
10.1136/GUT.2009.203893
P407
P50
P577
2010-06-28T00:00:00Z